Home › Infertility › NCT07004192
The Role of hCG in Thawed Embryo Transfer
RecruitingPhase 4Healthy volunteers welcome
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. Female adult expecting to receive transfer of a thawed embryo. 2. At least one available frozen blastocyst of transferrable quality. 3. Non-menopausal female with at least one antral follicle. 4. Use of pre-implantation genetic testing (PGT), embryos derived from donor oocytes and/or donor sperm, a gestational carrier, and history of prior transfer(s) regardless of outcome are allowed. 5. Subsequent embryo transfers after failed transfers under this study are allowed, but not after a transfer that has resulted in ongoing pregnancy at ten weeks gestation under this study. Exclusion Criteria: 1. Minors (age\<18 years). 2. Use of embryo(s) frozen at another center. 3. Patient insistent on transfer of two embryos. 4. Patient or partner unable to provide informed consent in English. 5. Patient already enrolled in any other research study for her embryo transfer. 6. History of anti-phospholipid syndrome or any other indication for use of Lovenox in pregnancy. 7. Patient for whom the physician assesses this protocol is inappropriate or unsafe.
About the study
This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
What is being tested
- HCG injection (drug)
- No intervention (other)
Sponsor: Fertility Center of Las Vegas · Participants: 220 · Started: Jun 2, 2025
Contact the study team
- Shironda Research Assistant · Phone: 702-254-1777
Official record on ClinicalTrials.gov — NCT07004192
Locations in the U.S.
| Nevada | Fertility Center of Las Vegas, Las Vegas |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.